MSFT$517.99▼1.1%
AAPL$352.78▼1.0%
GOOGL$283.72▼4.1%
AMZN$257.75▼3.3%
TSLA$379.74▼2.7%
BTC$65.1k▲1.4%
ETH$1.8k▲1.3%
LTC$45.26▲2.3%
DOGE$0.06▲1.9%
XRP$0.97▲2.4%
MSFT$517.99▼1.1%
AAPL$352.78▼1.0%
GOOGL$283.72▼4.1%
AMZN$257.75▼3.3%
TSLA$379.74▼2.7%
BTC$65.1k▲1.4%
ETH$1.8k▲1.3%
LTC$45.26▲2.3%
DOGE$0.06▲1.9%
XRP$0.97▲2.4%

Latest News

November 17, 2026
scienceNov 17 2026
LA Times Launches Free Medical Journal JBMS

LA Times Launches Free Medical Journal JBMS

LA Times Studios rolled out a brand‑new open‑access medical journal called JBMS on October 28, 2026. The goal is to fill missing pieces in how research gets published. Anyone can read the papers online for free because the journal uses a CC BY 4. 0 license. Each article gets a permanent DOI from Crossref and is stored long‑term in Portico. The first special issue focuses on immuno‑oncology, which studies how the immune system fights cancer. It mixes lab work, studies that move findings toward patients, and trials with people. Key topics include how tumors interact with immunity, treatment response and resistance, biomarkers, and new therapy ideas. JBMS uses a double‑blind review, so reviewers and authors stay anonymous. Each paper gets looked at by at least two independent reviewers after an initial screen. The board has 50 experts, four co‑editors, and 75 reviewers who are clinicians or researchers. Before launch, ten papers came in from scientists around the world. Authors who qualify can publish without paying fees, and early‑career researchers get mentorship and lower costs. LA Times Studios will boost the work through interviews, podcasts, videos and easy summaries for patients. Anna Magzanyan, president of JBMS and LA Times Studios, says the project aims to create an open, inclusive space for researchers, doctors and patients. LA Times Studios belongs to the Los Angeles Times Media Group.

Read full story